Chemoinformaics analysis of 16-OXOPROMETAPHANINE
| Molecular Weight | 373.405 | nRot | 3 |
| Heavy Atom Molecular Weight | 350.221 | nRig | 22 |
| Exact Molecular Weight | 373.153 | nRing | 4 |
| Solubility: LogS | -2.982 | nHRing | 1 |
| Solubility: LogP | 0.636 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 2 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 27 | No. of Aromatic Carbocycles | 1 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 23 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 6 | No. of Arom Bond | 6 |
| nHA | 6 | APOL | 54.6482 |
| nHD | 1 | BPOL | 31.7278 |
| QED | 0.864 |
| Synth | 4.383 |
| Natural Product Likeliness | 2.141 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.947 |
| Pgp-sub | 0.028 |
| HIA | 0.173 |
| CACO-2 | -4.721 |
| MDCK | 0.0000197 |
| BBB | 0.948 |
| PPB | 0.52384 |
| VDSS | 0.904 |
| FU | 0.395968 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.914 |
| CYP2c19-inh | 0.09 |
| CYP2c19-sub | 0.942 |
| CYP2c9-inh | 0.058 |
| CYP2c9-sub | 0.387 |
| CYP2d6-inh | 0.001 |
| CYP2d6-sub | 0.36 |
| CYP3a4-inh | 0.272 |
| CYP3a4-sub | 0.942 |
| CL | 5.199 |
| T12 | 0.372 |
| hERG | 0.011 |
| Ames | 0.029 |
| ROA | 0.65 |
| SkinSen | 0.034 |
| Carcinogencity | 0.118 |
| EI | 0.011 |
| Respiratory | 0.039 |
| NR-Aromatase | 0.801 |
| Antiviral | Yes |
| Prediction | 0.553284 |